[TOXIC EPIDERMAL NECROLYSIS (LYELL'S SYNDROME)].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001706:Biopsy; D002301:Cardiac Glycosides; D002648:Child; D002751:Chlortetracycline; D003879:Dermatologic Agents; D003933:Diagnosis; D006801:Humans; D010336:Pathology; D010406:Penicillins; D011241:Prednisone / Q000627:therapeutic use*; D013262:Stevens-Johnson Syndrome; D013307:Streptomycin
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002301:Cardiac Glycosides; D003879:Dermatologic Agents; D010406:Penicillins; D000324:Adrenocorticotropic Hormone; D001205:Ascorbic Acid; D011241:Prednisone; D002751:Chlortetracycline; D013307:Streptomycin
ANTIBIOTICS; ASCORBIC ACID, THERAPEUTIC; BIOPSY; CARDIAC GLYCOSIDES; CHILD; CHLORTETRACYCLINE; CORTICOTROPIN, THERAPEUTIC; DIAGNOSIS; EPIDERMAL NECROLYSIS, TOXIC; PATHOLOGY; PENICILLIN; PREDNISONE, THERAPEUTIC; STREPTOMYCIN
TOXIC EPIDERMAL NECROLYSIS (SYNDROME DE LYELL)